| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
114,230,000 |
| Market
Cap: |
282.15(M) |
| Last
Volume: |
30,263,969 |
Avg
Vol: |
7,471,600 |
| 52
Week Range: |
$2.47 - $2.47 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ BIOTECHNOLOGY |
| |
NASDAQ COMPOSITE |
|
S&P 400 MIDCAP |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Garcia Peter S |
Vice President, CFO |
• – – |
2015-12-15 |
4 |
B |
$3.64 |
$18,200 |
D/D |
5,000 |
126,041 |
2.74 |
- |
|
| Garcia Peter S |
Vice President, CFO |
• – – |
2015-12-14 |
4 |
B |
$3.42 |
$34,245 |
D/D |
10,000 |
121,041 |
2.74 |
- |
|
| Pietzke Steffen |
Controller and CAO |
• – – |
2015-12-07 |
4 |
B |
$3.64 |
$74,931 |
I/I |
20,590 |
20,590 |
1.99 |
- |
|
| Stone Christopher Lewis |
VP, Gen. Counsel & Secretary |
• – – |
2015-09-29 |
4 |
A |
$4.95 |
$75,690 |
D/D |
15,291 |
155,764 |
|
- |
|
| Garcia Peter S |
Vice President, CFO |
• – – |
2015-09-29 |
4 |
A |
$4.95 |
$75,087 |
D/D |
15,169 |
111,041 |
|
- |
|
| Hart Danny J Jr. |
VP Business Development |
• – – |
2015-09-29 |
4 |
A |
$4.95 |
$87,001 |
D/D |
17,576 |
95,496 |
|
- |
|
| Pietzke Steffen |
Controller and CAO |
• – – |
2015-09-29 |
4 |
A |
$4.95 |
$9,113 |
D/D |
1,841 |
16,589 |
|
- |
|
| Saks Samuel R |
Director |
– • – |
2015-09-14 |
4 |
A |
$5.34 |
$150,001 |
D/D |
28,090 |
28,090 |
|
- |
|
| Edick Paul R |
Director |
– • – |
2015-09-08 |
4 |
A |
$5.27 |
$150,000 |
D/D |
28,463 |
28,463 |
|
- |
|
| Garcia Peter S |
Vice President, CFO |
• – – |
2015-08-14 |
4 |
B |
$5.79 |
$57,903 |
D/D |
10,000 |
95,872 |
2.74 |
- |
|
| Garcia Peter S |
Vice President, CFO |
• – – |
2015-08-13 |
4 |
B |
$5.86 |
$58,599 |
D/D |
10,000 |
85,872 |
2.74 |
- |
|
| Pietzke Steffen |
Controller and CAO |
• – – |
2015-07-06 |
4 |
A |
$6.18 |
$91,143 |
D/D |
14,748 |
14,748 |
|
- |
|
| Sandman Paul W |
Director |
– • – |
2015-05-28 |
4 |
A |
$6.80 |
$150,001 |
D/D |
22,059 |
76,700 |
|
- |
|
| Gryska David W |
Director |
– • – |
2015-05-28 |
4 |
A |
$6.80 |
$150,001 |
D/D |
22,059 |
33,411 |
|
- |
|
| Lindell Jody S |
Director |
– • – |
2015-05-28 |
4 |
A |
$6.80 |
$150,001 |
D/D |
22,059 |
70,074 |
|
- |
|
| Selick Harold E |
Director |
– • – |
2015-05-28 |
4 |
A |
$6.80 |
$150,001 |
D/D |
22,059 |
70,728 |
|
- |
|
| Immune Response Biopharma, Inc. |
|
– – – |
2015-05-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1 |
|
- |
|
| Hart Danny J Jr. |
VP Business Development |
• – – |
2015-01-28 |
4 |
A |
$7.62 |
$217,498 |
D/D |
28,543 |
77,920 |
|
- |
|
| Montez David |
Controller and CAO |
• – – |
2015-01-28 |
4 |
A |
$7.62 |
$91,143 |
D/D |
11,961 |
26,719 |
|
- |
|
| Garcia Peter S |
Vice President, CFO |
• – – |
2015-01-28 |
4 |
A |
$7.62 |
$250,294 |
D/D |
32,847 |
75,872 |
|
- |
|
| Stone Christopher Lewis |
VP, Gen. Counsel & Secretary |
• – – |
2015-01-28 |
4 |
A |
$7.62 |
$252,298 |
D/D |
33,110 |
140,473 |
|
- |
|
| Mclaughlin John Peter |
President, CEO |
• – – |
2015-01-28 |
4 |
A |
$7.62 |
$984,512 |
D/D |
129,201 |
417,669 |
|
- |
|
| Selick Harold E |
Director |
– • – |
2014-11-26 |
4 |
B |
$8.08 |
$48,487 |
D/D |
6,000 |
48,669 |
2.39 |
- |
|
| Hart Danny J Jr. |
VP Business Development |
• – – |
2014-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,611 |
49,377 |
|
- |
|
| Lindell Jody S |
Director |
– • – |
2014-05-28 |
4 |
A |
$9.31 |
$50,004 |
D/D |
5,371 |
48,015 |
|
- |
|
134 Records found
|
|
Page 5 of 6 |
|
|
